RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:CBN product developmentWell they wouldn't even need an exit clause. They'd need only not renew . Except here's the thing, while I haven't tried Tabletz yet, I have tried Neuenegy (in fact just again this morning to get my a$$ out of the house after a terrible nights sleep). It's a great product that works at least as well as advertised . Since all products are using the same IP I can only imagine the other products will work just as well. Even with delays we'll still be a year + ahead of any notable competition in Japan due to the pause (right after us) of any new cbd product approvals . At just nominal sales there's enough money to be made that I just can't see anyone not renewing (unless none sell lol). Yeah I'm frustrated but overall I see great success here.